EUTM file information

004832671

BRYVEO


January 1, 2006

Trademark Summary

The trademark BRYVEO was filed by Agouron Pharmaceuticals, LLC, a Limited Liability Company (the "Applicant"). The application was published for oppositions on July 9, 2006, and received one opposition filed on October 8, 2006 by Wegold Edelmetalle AG on Likelihood of confusion. the opponent was represented by EISENFÜHR SPEISER PATENTANWÄLTE RECHTSANWÄLTE PARTGMBB and proceedings were handled in German, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued October 8, 2006

The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).

The renewal of the trademark was recorded by the office on November 5, 2016.

of the trademark registration was recorded on November 5, 2016. Change of name and professional address of the trademark registration was recorded on April 5, 2009. Appointment and Replacement of representative of the trademark registration was recorded on October 9, 2012. Change of name and address of the trademark registration was recorded on February 2, 2016.


Goods And Services

  • The mark was filed in class 5 with Pharmaceutical preparations for the treatment of macular degeneration, disorders of the eye, cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, premature ejaculation, stroke, cancer, migraines, pain, obesity, inflammation, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, viral disorders and fungal disorders and pharmaceutical preparations namely, cholesterol preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations and ophthalmological preparations..